Company Profiles

driven by the PitchBook Platform

Nora Therapeutics

Nora Therapeutics
1992 FOUNDED
PRIVATE STATUS
Conv. Debt LATEST DEAL TYPE
$1M LATEST DEAL AMOUNT
6 INVESTORS
Description

Provider of biotechnology services intended to address significant unmet needs in reproductive medicine. The company's biotechnology services reduces the risk of miscarriage in women who have a history of unexplained recurrent miscarriage and develops a novel biologic agent similar to a naturally occurring protein in the female reproductive tract, enabling pregnant women to maintain pregnancy by optimizing maternal-fetal immune tolerance.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Therapeutic Devices
Primary Office
  • 530 Lytton Avenue
  • 2nd floor
  • Palo Alto, CA 94301
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nora Therapeutics’s full profile, request a free trial.

Nora Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Convertible Debt 13-Oct-2015 $1M 000.00 Completed Clinical Trials - Phase 2
2. Later Stage VC (Series B) 17-Apr-2014 0000 000.00 000.00 Completed Clinical Trials - Phase 2
1. Later Stage VC (Series A) 01-Sep-2010 $34.9M $34.9M 000.00 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Nora Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Nora Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
TEDCO Venture Capital Minority 000 0000 000000 0
Novo Holdings Corporate Venture Capital Minority 000 0000 000000 0
Burrill & Co Merchant Banking Firm Minority 000 0000 000000 0
Prospect Venture Partners Venture Capital Minority 000 0000 000000 0
Rho Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Nora Therapeutics Executive Team (6)

Name Title Board
Seat
Contact
Info
Chris McClain Executive Director, Business Affairs & Co-Founder
Darryl Carter MD Co-Founder & Vice President, Research
Sandra Shpilberg Vice President, Strategic Marketing & Commercial Planning

3 Former Executives

You’re viewing 3 of 6 executives. Get the full list »

Nora Therapeutics Board Members (11)

Name Representing Role Since Contact
Info
Anupam Dalal MD Self Board Member 000 0000
Chen-Ming Yu MD Vivo Capital Board Member 000 0000
David Schnell MD Prospect Venture Partners Board Member 000 0000
Dennis Fenton Ph.D Self Board Member 000 0000
Donald Hayden Jr. Prospect Venture Partners Chairman 000 0000

2 Former Board Members

You’re viewing 5 of 11 board members. Get the full list »